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Summary  
Background 
Healthcare associated infections (HAI) are a major public health concern and a 
significant cause of morbidity and mortality. A robust and current evidence base that 
is specific to local, national and Europe-wide settings is necessary to inform the 
development of strategies to reduce HAI and contain antimicrobial resistance (AMR). 
Aim  
To measure the prevalence of HAI and antimicrobial prescribing and identify key 
priority areas for interventions to reduce the burden of infection.  
Methods 
A national rolling PPS in National Health Service (NHS) acute, NHS non-acute, NHS 
paediatric and independent hospitals was carried out between September and 
November 2016 using the European Centre for Disease Prevention and Control 
protocol designed for the European PPS. 
 
Findings  
The prevalence of HAI was 4.6%, 2.7% and 3.2% in acute adults, paediatric and 
non-acute patient groups, respectively. The most common HAI types reported in 
adult patients were urinary tract infection and pneumonia. The prevalence of 
antimicrobial prescribing was 35.7%, 29.3% and 13.8% in acute adults, paediatric 
and non-acute patient groups, respectively. Respiratory, skin and soft tissue, 
gastrointestinal and urinary tract infections were the most common infections being 
treated at the time of survey. 
Conclusion 
HAI continues to be a public health concern in Scotland. UTI and pneumonia 
continue to place a significant burden on patients and on healthcare delivery, 
including those that develop in the community and require hospital admission. A 
broader population health approach which focuses on reducing the risk of infection 
upstream would reduce these infections in both community and hospital settings.   
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Introduction 
 
Healthcare associated infections (HAI) are a major public health concern and a 
significant cause of morbidity and mortality globally.1 The European Centre for 
Disease Prevention and Control (ECDC) estimates that 3.2 million patients develop a 
HAI every year in Europe.2 A significant proportion of HAI are considered to be 
avoidable and prevention of these infections provides an opportunity to improve 
patient outcome and reduce unnecessary costs within healthcare systems.3  
A robust and current evidence base that is specific to local, national and Europe-
wide settings is necessary to inform the development of strategies to reduce HAI and 
contain antimicrobial resistance (AMR).4 In response to a European Union (EU) 
Council Recommendation on patient safety, including prevention and control of HAI5, 
ECDC developed a standardised point prevalence survey (PPS) protocol which has 
been used in two Europe-wide PPS.6  
National PPS are undertaken every five years in Scotland in order to take stock of 
the current epidemiological situation and to review local and national policy. To date, 
there have been three national PPS undertaken in Scotland; 2005/67, 20118 and 
2016.9  Both of the latter surveys were undertaken using the ECDC protocol and 
contributed to the Europe-wide surveys. The results from the third Scottish PPS will 
inform the development of key priority areas and recommendations for the 
prevention and control of infection and antimicrobial stewardship programmes.  
This paper describes the headline results from the Scottish 2016 PPS, focusing on 
urinary tract infections and pneumonia, and highlights the need for a broader public 
health approach for prevention of infection across all settings.    
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Methods 
 
Study design 
 
A rolling point prevalence survey was carried out in Scottish hospitals during 
September, October and November 2016. The Scottish protocol was developed 
using the ECDC protocol for PPS.6 The survey included all National Health Service 
(NHS) acute, NHS paediatric and independent hospitals, and a 25% sample of NHS 
non-acute hospitals.  
Data were collected by trained teams of staff from local Infection Prevention and 
Control Teams (IPCT) and Antimicrobial Management Teams (AMT). Data were 
extracted from a number of sources available on the ward at the time of survey. The 
ECDC case definitions for HAI were used.6 Full details of the study design and data 
collection methods are provided in the Scottish PPS protocol.10 
 
Analysis 
 
The acute and paediatric surveys of all hospitals were analysed as cluster samples 
with wards nested within hospitals. The non-acute survey was a stratified 
(psychiatry/non-psychiatry) cluster sample with hospitals selected in proportion to 
size within each stratum. Sample weights were also used in the non-acute survey to 
compensate for under-sampling in the psychiatry strata as low prevalence was 
anticipated and there were large hospitals in this stratum. The prevalence of HAI in 
the acute adult inpatient sample was also stratified by hospital type according to 
ECDC definitions (primary, secondary specialised and tertiary).6 Survey mean 
clustered CI were used when the sample size was large (acute adult patient group 
and total acute hospital population).Wilson’s unadjusted confidence intervals (CI) 
were used when the prevalence was low and the sample size small (paediatric and 
non-acute patient groups).  Statistical analysis was carried out using R version 3.3.1 
and the ‘survey’ library.11 
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Onsite gold standard validation study 
 
A gold standard validation study was carried out concurrently with the national PPS 
using the Scottish PPS validation protocol which was based on the ECDC PPS 
Validation Protocol.12 The sensitivity and specificity for the presence of HAI and 
antimicrobials were calculated with 95% CI. 
 
Extrapolation of the gold standard validation results to HAI prevalence  
 
The results from the gold standard validation were used to calculate an adjusted 
prevalence of HAI that accounted for possible under- or over-reporting by the local 
data collection teams. The sensitivity and specificity were used to adjust the 
prevalence and bootstrapping methods were used to calculate the 95% CI around 
the adjusted prevalence. The bootstrapping methods accounted for sampling 
variation in the sensitivity/specificity estimates and the prevalence estimate. 
 
Estimation of the burden of HAI   
 
The ECDC methodology for calculating the burden of HAI was used to estimate the 
burden of HAI.2 The Rhame and Sudderth equation13 was applied to the prevalence 
figure adjusted to control for the potential under-reporting identified by the gold 
standard validation: 
Incidence = prevalence * (length of stay / (date of survey - date of onset)) 
The average length of stay in Scottish acute adult patients was estimated using data 
from national datasets.14 The mean and median difference between date of onset of 
HAI and date of survey were used in the equation. The incidence calculated using 
the mean and the median was averaged. The resulting incidence was then applied to 
the annual number of acute adult inpatient stays to estimate the number of HAI per 
year in acute adult inpatients in Scotland. The 95% confidence interval was 
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calculated using bootstrapping methods to propagate the uncertainty from the 
prevalence adjustment that was based on the gold standard validation results. 
  
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
6 
 
Results 
 
Survey population 
 
A total of 11 627 acute hospital patients (acute, paediatric and independent 
hospitals) and 1083 non-acute hospital patients were included in the survey. The 
median ages of patients surveyed in acute and non-acute hospitals were 71 years 
(range 0 to 102, inter-quartile range (IQR) 52 to 82) and 80 years (range 17 to 104, 
IQR 69 to 87), respectively. Two fifths of patients surveyed in acute hospitals 
(40.0%, n=4609) and 65.7% in non-acute hospitals (n=697) had the most severe co-
morbidity scores (ultimately fatal or rapidly fatal McCabe15 score). 
 
Prevalence of HAI 
 
The prevalence of HAI by patient group and by hospital type in the acute adult 
population is described in Table I. The distributions of HAI types in the four patient 
groups are described in Table II. A total of 527 HAI occurring in 497 acute adult 
inpatients, 20 HAI in 20 paediatric inpatients and 34 HAI in 34 non-acute inpatients 
were reported. The causative micro-organisms are described in Table III. A total of 
323 of the HAI met the case definition without positive microbiology at the time of 
survey (55.6%). 
 
Prevalence of antimicrobial prescribing  
 
The prevalence of antimicrobial prescribing by patient group is described in Table IV. 
A total of 6381 antimicrobials were prescribed in the surveyed patients. The 
distributions of the types of infections being treated at the time of survey are 
described in Table V. 
 
  
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
7 
 
Gold standard validation results 
 
A total of 258 patients in nine hospitals were included in the gold standard validation 
exercise. Ten of the included patients had a HAI and 109 patients were receiving 
antimicrobials at the time of survey. The sensitivity and specificity of the HAI data 
item were 60% (95% CI: 31.3 to 83.2) and 100% (95% CI: 98.5 to 100), respectively. 
The sensitivity and specificity of the antimicrobial data were 89.0% (95% CI: 81.7 to 
93.6) and 97.8% (95% CI: 93.8 to 99.6), respectively.  
 
Extrapolation of the gold standard validation results to HAI prevalence  
 
The sensitivity was used to adjust the reported prevalence of HAI in acute adult 
patients by assuming that the false negative rate was 40% in the primary data 
collection. As the specificity was 100%, no adjustment for the false positive rate was 
undertaken. The prevalence before adjustment was 4.6% and after adjustment for 
the estimated under-reporting was 7.7% (95% CI: 5.1 to 15.8).  
 
Burden of HAI  
 
The incidence of HAI was calculated using the mean and median duration between 
date of onset and date of survey; 7.6 days and 5 days, respectively. The estimated 
length of stay in acute adult inpatients was 6.7 days.14 The estimated prevalence 
was calculated using the adjusted prevalence (7.7%). The incidences of HAI 
calculated using the mean and median duration were 6.7% and 10.2%, respectively 
and the average incidence was 8.4%. Application of the incidence to the number of 
hospital stays in Scotland (n= 655 061), resulted in an estimate that there are 55 307 
HAI in acute adult inpatients each year in Scotland (95% CI: 35 000 to 108 000). 
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Discussion 
 
The third Scottish national PPS reported that, whilst the prevalence of HAI was 
significantly lower in acute adult inpatients than in 2011 (4.6% versus 5.0%, 
p=0.03)8;9, there is still a high burden of HAI in Scottish acute hospitals wherein one 
in 22 patients (4.5%) at any one time have an HAI. This is equivalent to one patient 
on every ward, every day, in every acute hospital in Scotland with an infection 
associated with the care they have received in hospital. A gold standard validation 
study identified likely under-reporting of HAI and after adjustment to account for this, 
the prevalence was estimated to be 7.7%. This accounts for an estimated 55 500 
HAI per year in acute adult patients in Scotland.  
The patient population was older and sicker than five years earlier8;9 and this has 
important implications for the risk of HAI. These differences likely reflect the 
continuing change in the demographics of the general population. The number of 
people aged 75 years and over in Scotland is projected to increase by approximately 
29% between 2014 and 2024.16 The changing demographics of the population has 
important implications for infection risk, including the risk of HAI, with older patients 
at an increased risk of developing infection, both in hospital and in the community.17-
19
 
The most common HAI types differed between adult and paediatric patients and this 
reflects differences in risk in these patient groups. In paediatric patients, the 
epidemiological picture of clinical sepsis and bloodstream infection is similar to that 
reported in Scotland and more widely across Europe during the 2011 PPS.2;8 An 
epidemiological review of all of the European paediatric data collected during the 
2011/12 survey recommended that infection prevention and control strategies should 
focus on prevention of BSI, particularly among neonates and infants.20 The most 
common HAI (UTI and pneumonia) reported in the adult patients in this survey reflect 
the elderly population in acute and non-acute hospital settings. These HAI were also 
the most commonly reported in the 2011 Scottish and European surveys2;8 
confirming the continuing need for focused action to tackle the burden of these 
infections. Importantly, this survey has identified that a significant proportion of these 
infections were not associated with the use of invasive devices.9 Traditionally, 
interventions to prevent UTI and pneumonia in healthcare settings have focused on 
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catheter associated urinary tract infections and ventilator associated pneumonia. A 
recent review of guidance and literature relating to pneumonia in non-ventilated 
patients reported that there was a lack of evidence for preventative measures and no 
specific national guidance had been issued by professional societies or professional 
medical associations for the prevention of these infections.21 The main focus of the 
current National Institute for Health and Care Excellence (NICE) guideline is the 
management of community acquired pneumonia rather than prevention.22 The 
development of national multimodal programmes for the prevention of pneumonia 
and urinary tract infections across all healthcare settings has the potential for 
significant impact.23;24 These programmes should include the development of new 
targeted IPC interventions such as guidelines and quality improvement tools; 
strengthen IPC and stewardship across all healthcare settings; and promote broader 
public health interventions, such improving hydration, nutrition 25;26 and 
mobilisation21, in order to reduce the risk of infection in the older population. 
The types of HAI reported are commonly associated with Gram negative organisms 
where the greatest threat of AMR currently lies. E. coli, for the first time, was the 
most commonly reported causative organism. This is a change from the last two 
PPS in Scotland wherein S. aureus was the most frequently reported.8;9 Preventing 
the spread of these micro-organisms in hospital settings is an essential component 
of controlling antimicrobial resistance alongside protecting and stewarding the use of 
antimicrobials.27-29 
 
More than a third of acute adults inpatients were receiving one or more 
antimicrobials and this was higher than five years ago after accounting for 
differences in patient case mix (35.7% versus 33.2%, p=0.01).8;9 Importantly, this 
survey highlights that the types of infection occurring in Scottish hospitals were also 
associated with a large burden of prescribing to treat community acquired infection in 
hospital. Reducing the risk of developing UTI and pneumonia in the older population 
both before and during hospital admissions would reduce the burden that these 
infections place on the healthcare system as a whole and prevent the unnecessary 
use of antimicrobials. 
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There are methodological limitations to prevalence surveys that must be 
acknowledged. Prevalence surveys represent only the time of survey and the cross 
sectional approach is biased towards identifying HAI of longer duration and patients 
with a longer length of stay are overrepresented in prevalence surveys. The 
adjustment of HAI prevalence using the results from the gold standard validation was 
based on a small number of validated HAI. The prevalence of HAI in the primary 
survey and the validation survey differed and this may have affected the 
extrapolation as the predictive values may be different in the primary survey. In 
addition, the burden calculation was based on single parameters whilst previous 
calculations, including those used in the previous ECDC survey2, were based on 
modelled parameters. 
 
In conclusion, the results from this third national PPS highlight the continuing burden 
that UTI and pneumonia are placing on hospitals including those developing in the 
community requiring admission.  Given the changes to the way care is delivered and 
will be delivered in the future30, it is appropriate that a population health approach 
which includes both IPC and broader public health interventions, and focuses on 
reducing the risk of infection upstream, before admission to hospital, is developed. 
Such an approach would reduce community acquired infections and the associated 
prescribing and risk of AMR; reduce the need for hospital admission for infections 
and reduce the risk of patients developing a HAI should they require to be admitted 
to hospital. 
Acknowledgements 
 
This survey would not have been completed successfully and within schedule 
without the cooperation and support of local Infection Control and Antimicrobial 
Management Teams in all of the participating hospitals. Their collaboration is 
gratefully acknowledged.  
Conflict of Interests 
None declared.  
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
11 
 
Source of Funding 
This project was funded by the Scottish Government. 
  
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
12 
 
References 
 
1. World Health Organization. Report on the Burden of Endemic Health Care-
Associated Infection Worldwide. Geneva: WHO; 2011. 
2. European Centre for Disease Prevention and Control. Point prevalence 
survey of healthcare-associated infection and antimicrobial use in European acute 
care hospitals 2011- 2012. Stockholm: ECDC; 2013. 
3. Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial 
infections: an overview of published reports. J Hosp Infect 2003;54:258-66. 
4. Reilly J, Stewart S, Allardice G, Cairns S, Ritchie L, Bruce J. Evidence-based 
infection control planning based on national healthcare-associated infection 
prevalence data. Infect Control Hosp Epidemiol 2009;30:187-189 
5. European Commission. Council Recommendation on patient safety, including 
the prevention and control of healthcare associated infections (2009/C 151/01). 
Brussels: European Council; 2009. 
6. European Centre for Disease Prevention and Control. Point prevalence 
survey of healthcare-associated infections and antimicrobial use in European acute 
care hospitals - protocol version 5.3. Stockholm: ECDC; 2015.  
7. Health Protection Scotland. NHS Scotland National HAI Prevalence Survey. 
Final Report 2007. Glasgow: HPS; 2007. 
8. Health Protection Scotland. Scottish National Point Prevalence Survey of 
Healthcare Associated Infection and Antimicrobial Prescribing 2011. Glasgow: HPS; 
2012. 
9. Health Protection Scotland. National Point Prevalence Survey of Healthcare 
Associated Infection and Antimicrobial Prescribing 2016. Glasgow: HPS; 2017. 
10. Health Protection Scotland. Point Prevalence Survey of Healthcare 
Associated Infection and Antimicrobial Prescribing 2016: Protocol for the collection of 
patient and ward level data. Glasgow: HPS; 2016. 
11. Lumley T. Analysis of Complex Survey Samples. J. Stat. Softw 2004:1;1-19. 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
13 
 
12. European Centre for Disease Prevention and Control. Point prevalence 
survey of healthcare associated infections and antimicrobial use in European acute 
care hospitals. PPS Validation Protocol Version 3.1. Stockholm: ECDC; 2015. 
13. Rhame FS, Sudderth WD. Incidence and prevalence as used in the analysis 
of the occurrence of nosocomial infections. Am J Epidemiol 1981;113:1-11. 
14. Information Services Division. Average length of stay in hospital, by admission 
type and specialty, Scotland. Edinburgh: ISD; 2016.  
15. McCabe WR, Jackson GG. Gram-negative bacteraemia. Etiology and 
ecology. Arch Intern Med 1962;110:845 
16. National Records of Scotland. Projected Population of Scotland (2014-based). 
Edinburgh: NRS; 2015. 
17. Paillaud E, Herbaud S, Caillet P, Lejonc JL, Campillo B, Bories PN. Relations 
between undernutrition and nosocomial infections in elderly patients. Age Ageing 
2005;34:619-25. 
18. Parker SG, Fadayevatan R, Lee SD. Acute hospital care for frail older people. 
Age Ageing 2006;35:551-2. 
19. Strausbaugh LJ. Emerging health care-associated infections in the geriatric 
population. Emerg Infect Dis 2001;7:268-71. 
20. Zingg W, Hopkins S, Gayet-Ageron A, et al. Health-care-associated infections 
in neonates, children, and adolescents: an analysis of paediatric data from the 
European Centre for Disease Prevention and Control point-prevalence survey. 
Lancet Infect Dis 2017;17:01. 
21. Passaro L, Harbarth S, Landelle C. Prevention of hospital-acquired 
pneumonia in non-ventilated adult patients: a narrative review. Antimicrob Resist 
Infect Control 2016;5:43-54. 
22. National Institute for Health and Care Excellence. Pneumonia in adults: 
diagnosis and management. London: NICE; 2014. 
 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
14 
 
23.   Zingg W, Holmes A, Dettenkofer M, Goetting T, Secci F, Clack L, et al. 
Hospital organisation, management, and structure for prevention of health-care-
associated infection: A systematic review and expert consensus. Lancet Infect Dis 
2015;15:212-224  
24.   Montoya A, Cassone M, Mody L. Infections in Nursing Homes: Epidemiology 
and Prevention Programs. Clin Geriatr Med 2016;32:585-607. 
25.  Healthcare Improvement Scotland. Food, Fluid and Nutritional Care 
Standards. Glasgow: HIS; 2014.  
26.  Department of Health. The Hospital Food Standards Panel's report on 
standards for food and drink in NHS hospitals. London: Department of Health; 2014. 
27. World Health Organization. Global Action Plan on Antimicrobial Resistance. 
Geneva: WHO; 2015.  
28. Public Health England. UK Five Year Antimicrobial Resistance Strategy 2013 
to 2018. London: PHE; 2013. 
29. Wilson APR, Livermore DM, Otter JA, et al. Prevention and control of multi-
drug-resistant Gram-negative bacteria: recommendations from a Joint Working 
Party. J Hosp Infect 2016;92:S1-S44. 
30. National Audit Office. Health and social care integration. London: NAO; 2017. 
 
  
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
15 
 
Table I: Prevalence of HAI in Scotland in 2016, by patient group 
Patient group 
Number of patients 
surveyed* 
Number of 
patients 
with HAI 
Prevalence 
(%) 
95% 
Lower CI 
95% Upper 
CI 
Acute adult 
patients  10 813 497 4.6 4.1 5.1 
Primary 682 32 4.7 3.3 6.5 
Secondary 5133 214 4.2 3.7 4.8 
Specialised 253 7 2.8 1.3 5.6 
Tertiary 4745 244 5.1 4.5 5.8 
Paediatric patients 734 20 2.7 1.8 4.2 
Total acute 
patients 11 547 517 4.5 4 5 
Non-acute patients 1079 34 3.2 2.3 4.4 
* Number of patients surveyed with HAI status recorded. HAI data for acute adult, paediatric and non-acute 
patients were not recorded for 76, 4 and 4 patients, respectively 
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Table II: Distribution of HAI types in Scotland in 2016, by patient group 
HAI Type 
Acute adult 
patients 
Paediatric 
patients 
Non-acute adult 
patients 
N % N % N % 
Urinary tract infection 129 24.5 0 0.0 20 58.8 
Pneumonia 118 22.4 2 10.0 4 11.8 
Surgical site infection 87 16.5 2 10.0 3 8.8 
Laboratory-confirmed BSI 46 8.7 4 20.0 1 2.9 
Skin and soft tissue infection 38 7.2 1 5.0 2 5.9 
Eye, ear, nose, throat or mouth 
infection 29 5.5 
0 
0.0 
0 0.0 
Gastrointestinal tract infection 27 5.1 2 10.0 2 5.9 
Systemic infection 17 3.2 9 45.0 1 2.9 
CVC/PVC related infection 16 3.0 0 0.0 0 0.0 
Lower respiratory tract 
infection, other than 
pneumonia 8 1.5 
0 
0.0 
1 2.9 
Bone/joint infection 4 0.8 0 0.0 0 0.0 
Cardiovascular system 
infection 4 0.8 
0 
0.0 
0 0.0 
Central nervous system 
infection 2 0.4 
0 
0.0 
0 0.0 
Reproductive tract infection 2 0.4 0 0.0 0 0.0 
Total 527 100 20 100 34 100 
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Table III: Distribution of reported causative micro-organisms in Scotland in 2016, by patient group 
Micro-organism 
Acute Adults Paediatric Non-acute adults 
N % N % N % 
Escherichia coli 64 22.7 2 25.0 11 61.1 
Staphylococcus aureus 57 20.2 2 25.0 2 11.1 
Clostridium difficile 15 5.3 0 0.0 1 5.6 
Enterococcus faecalis 10 3.6 2 25.0 0 0.0 
Klebsiella pneumoniae 10 3.6 0 0.0 1 5.6 
Klebsiella oxytoca 9 3.2 0 0.0 0 0.0 
Aspergillus niger 8 2.8 0 0.0 0 0.0 
Enterococcus faecium 8 2.8 0 0.0 0 0.0 
Anaerobes, not specified 7 2.5 0 0.0 0 0.0 
Candida species, not specified 7 2.5 0 0.0 0 0.0 
Staphylococcus epidermidis 7 2.5 1 12.5 0 0.0 
Haemophilus influenzae 6 2.1 0 0.0 0 0.0 
Proteus mirabilis 6 2.1 0 0.0 1 5.6 
Pseudomonas aeruginosa 6 2.1 0 0.0 1 5.6 
Other* 62 22.0 1 12.5 1 5.6 
Total 282 100.0 8 100.0 18 100.0 
* In acute adult patients, the “Other” group included 62 reports with less than five reports per micro-
organism, of which 30.6% were Gram negative bacilli  
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Table IV: Prevalence of antimicrobial prescribing in Scotland in 2016, by patient group 
Patient group 
Number of 
patients 
surveyed* 
Number of patients 
receiving an 
antimicrobial 
Prevalence 
(%) 
95% 
Lower 
CI 
95% 
Upper 
CI 
Acute adult patients 10 869 3878 35.7 34.2 37.2 
Paediatric patients 736 216 29.3 26.2 32.7 
Total acute patients 
11 605 4094 35.3 33.8 36.7 
Non-acute patients 1074 148 13.8 11.8 16.0 
* Number of patients surveyed with antimicrobial status recorded. Antimicrobial data for acute adult, paediatric 
and non-acute patients were not recorded for 20, 2 and 9 patients, respectively  
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Table V: Distribution of diagnoses for treatment of infection prescribing in Scotland in 2016, by patient group 
 
 
 
Diagnosis 
Acute adult patients Paediatric patients 
Non-acute 
patients 
N % N % N % 
Respiratory 1665 35.3 49 19.8 33 28.9 
Skin and soft tissue 828 17.5 21 8.5 30 26.3 
Gastrointestinal 727 15.4 23 9.3 1 0.9 
Urinary tract 651 13.8 18 7.3 41 36.0 
Systemic 441 9.3 102 41.3 3 2.6 
Ear, nose, throat 170 3.6 15 6.1 2 1.8 
Other/unspecified 86 1.8 5 2.0 3 2.6 
Cardiovascular 58 1.2 0 0.0 0 0.0 
Genitourinary 53 1.1 1 0.4 1 0.9 
Central nervous system 36 0.8 13 5.3 0 0.0 
Eye 3 0.1 0 0.0 0 0.0 
Not recorded 2 0.1 0 0.0 1 0.0 
Total 4720 100 247 100 115 100 
 
 
 
 
 
 
 
 
 
